Viewing Study NCT03007303


Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-03-09 @ 10:52 AM
Study NCT ID: NCT03007303
Status: UNKNOWN
Last Update Posted: 2020-01-30
First Post: 2016-11-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia Patients
Sponsor: Dalian Seventh People's Hospital
Organization:

Study Overview

Official Title: None
Status: UNKNOWN
Status Verified Date: 2020-01
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study investigates the relationship of circulating microRNA-30e and schizophrenia, and shows the relevance of the aberrant microRNA-30e expression in plasma with the variation disease status.
Detailed Description: The plasma samples from 15 individuals with schizophrenia (with a diagnosis of ICD-10) and the equivalent healthy controls will be conducted with the quantification analysis of the microRNA-30e via real-time quantitative polymerase chain reaction(RT-PCR).

The 15 patients enrolled should be the first-episode and have not been treated, or were drug free 3 months recently at least.

This research measures the expression level of microRNA-30e in schizophrenia respectively before the beginning treatment with atypical psychotics or combined with MECT, after the 4-week treated , the 8-week treated compared with 15 healthy controls.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: